Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund - Growth - Regular Plan

  • Previous Nav

  • Net Change on 03-02-2023

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The investment objective of the scheme is to adopt passive investment strategy. The fund will invest in stocks comprising in the MSCI India Domestic & World Healthcare 45 Index with the objective to provide investment returns that, before expenses, closely corresponds to the returns equivalent to the index, subject to tracking errors.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
MSCI India Domestic & World Healthcare 45 Index N/A N/A N/A N/A N/A N/A
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Taurus Ethical Fund - Regular Plan - Growth Option Mar 20, 2009 -4.90 13.85 10.41 2.41 85.40
Sundaram Nifty 100 Equal Weight Fund (Formerly Known as Principal Nifty 100 Equal Weight Fund)-Growth Jul 27, 1999 -4.66 14.56 7.13 0.95 55.69

Fund Holdings as on 31-December-2022

  • Sun Pharmaceutical Industries Ltd.

  • Cipla Ltd.

  • Dr. Reddy's Laboratories Ltd.

  • Divi's Laboratories Ltd.

  • Apollo Hospitals Enterprise Ltd.

  • Max Healthcare Institute Ltd.

  • JOHNSON & JOHNSON

  • ELI LILLY & CO

  • PFIZER INC

  • ABBVIE INC

  • MERCK & CO.INC

  • Torrent Pharmaceuticals Ltd.

  • THERMO FISHER SCIENTIFIC INC

  • Lupin Ltd.

  • NOVARTIS AG

  • ABBOTT LABORATORIES

  • DANAHER CORP

  • Laurus Labs Ltd.

  • Fortis Healthcare Ltd.

  • IPCA Laboratories Ltd.

  • Aurobindo Pharma Ltd.

  • Abbott India Ltd.

  • Biocon Ltd.

  • AMGEN INC

  • Dr. Lal Path Labs Ltd.

  • GILEAD SCIENCES INC

  • MEDTRONIC PLC

  • Syngene International Ltd.

  • INTUITIVE SURGICAL INC

  • Pfizer Ltd.

  • STRYKER CORP

  • Glenmark Pharmaceuticals Ltd.

  • Narayana Hrudayalaya ltd.

  • VERTEX PHARMACEUTICALS INC

  • BECTON DICKINSON AND CO

  • Suven Pharmaceuticals Ltd.

  • Sanofi India Ltd.

  • Ajanta Pharma Ltd.

  • GlaxoSmithKline Pharmaceuticals Ltd.

  • JB Chemicals & Pharmaceuticals Ltd.

  • MODERNA INC

  • Alembic Pharmaceuticals Ltd.

  • AGILENT TECHNOLOGIES INC

  • IQVIA HOLDINGS INC

  • ILLUMINA INC

  • Clearing Corporation of India Ltd.

  • Accrued Interest

  • Net Receivables/(Payables)

View More
  • Pharmaceuticals & Drugs

  • Miscellaneous

  • Hospital & Healthcare Services

View More

Fund Manager

  • Cash

  • Equity

View More

About Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund

Scheme Analysis

Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund is a Index Funds - Other fund and belongs to Edelweiss Mutual Fund. It was launched on 26-Oct-2020 and currently has an AUM of ₹140.86 crore. Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund is benchmarked against MSCI India Domestic & World Healthcare 45 Index as primary index and NIFTY 50 - TRI as secondary index.

The NAV of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund ended down ₹-0.08(-0.64%)yesterday to ₹11.9193.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Ltd., and

The Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund is managed by Bhavesh Jain and Amit Vora.

Fund House Contact

Edelweiss House Off. C.S.T Road, Kalina, Mumbai - 400 098

(022) 40933400
(022) 40933401